Twist Bioscience Corporation (TWST)
NASDAQ: TWST · Real-Time Price · USD
38.06
-2.31 (-5.71%)
Mar 31, 2025, 9:49 AM EDT - Market open
Twist Bioscience Revenue
Twist Bioscience had revenue of $88.71M in the quarter ending December 31, 2024, with 24.08% growth. This brings the company's revenue in the last twelve months to $330.19M, up 25.85% year-over-year. In the fiscal year ending September 30, 2024, Twist Bioscience had annual revenue of $312.97M with 27.69% growth.
Revenue (ttm)
$330.19M
Revenue Growth
+25.85%
P/S Ratio
7.14
Revenue / Employee
$357,735
Employees
923
Market Cap
2.27B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
TWST News
- 20 days ago - Twist Bioscience Offers Clonal Genes for Global Academic Researchers at Express Speed for No Extra Cost - Business Wire
- 4 weeks ago - Twist Bioscience to Present at Upcoming Investor Conferences - Business Wire
- 5 weeks ago - Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - Business Wire
- 7 weeks ago - Twist Bioscience: Valuation Is Weighing On The Stock - Seeking Alpha
- 7 weeks ago - Twist Bioscience Corporation (TWST) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Twist Bioscience Announces Fiscal 2025 First Quarter Financial Results - Business Wire
- 2 months ago - Gene Synthesis Market Size to Surpass USD 9.54 Billion by 2033 | Straits Research - GlobeNewsWire
- 2 months ago - Twist Bioscience to Report Fiscal 2025 First Quarter Financial Results on Monday, February 3, 2025 - Business Wire